Co-founder in Residence, Next Generation Therapeutics for Parkinson's Disease

TN United Kingdom; London; Remote; GBP 60,000 - 100,000; Full time

Job summary

A leading company is seeking a Co-founder in Residence to develop next-generation therapeutics for Parkinson's disease. This role involves venture creation, requiring a PhD in neuroscience and extensive knowledge of the disease. The position offers equity ownership and a supportive environment to innovate solutions.

Benefits

£250k launch investment

Guaranteed monthly income until launch

Majority equity ownership

Ongoing post-spin-out support

Qualifications

• PhD in neuroscience or related field required.
• Extensive knowledge of Parkinson’s disease at cellular and molecular levels.
• Experience in biotech/pharma with commercial awareness.

Responsibilities

• Work on all aspects of venture creation including problem-solving and team building.
• Develop a business case for a new company in the therapeutic area.
• Collaborate closely with the DSV team and partners.

Skills

Entrepreneurial spirit

Innovative mindset

Knowledge of Parkinson’s disease

Expertise in oxidative stress

Experience in drug discovery

Education

PhD in neuroscience or relevant field

Job description

Social network you want to login/join with:

Co-founder in Residence, Next Generation Therapeutics for Parkinson's Disease, London

Client: Deep Science Ventures

Location: London, United Kingdom

Job Category: Other

EU work permit required: Yes

Job Reference: f5cd45f101f7

Job Views: 6

Posted: 25.05.2025

Expiry Date: 09.07.2025

Job Description

ABOUT THE ROLE

At DSV, we’re looking for future Founders—entrepreneurially minded individuals with industry-specific technical and commercial domain expertise eager to solve urgent unmet challenges through venture building.

You will join DSV’s venture creation programme as a Founder in Residence, working closely with the DSV team to spin out a new company. During the programme, you’ll work on all aspects of venture creation in this opportunity area, including developing the approach to solve the problem, building a team, and creating a business case. Once incorporated with pre-seed investment from DSV, you and your co-founders will own the majority stake and continue to receive support from DSV.

The role is full-time, fully remote until venture incorporation and spin-out; location after TBD.

THE OPPORTUNITY AREA

Over 6 million individuals live with Parkinson’s disease today, projected to reach 12 million globally by 2040. Current therapies offer symptomatic relief but do not prevent disease progression. Emerging therapeutics often fail to translate from animal models to clinical success.

We are partnering with Parkinson’s UK to develop next-generation therapies targeting true disease-modifying nodes, addressing the multi-pathway pathology of PD.

OUR APPROACH

We aim to design therapies targeting master homeostatic regulators to correct multiple PD pathways, potentially slowing or reversing disease progression. This involves novel modalities and strategic target selection to overcome feedback mechanisms.

Requirements

WHO SHOULD APPLY

• PhD in neuroscience or relevant field
• Extensive knowledge of Parkinson’s disease at cellular and molecular levels
• Expertise in oxidative stress and neuroprotective pathways
• Experience in cellular, molecular, or biochemical drug discovery for CNS disorders
• Experience in biotech/pharma with commercial awareness
• Entrepreneurial spirit and innovative mindset
• Motivated to create curative solutions for PD

Preferred (nice-to-have):

• Knowledge of brain-specific drug delivery techniques
• Experience with nucleic acid payloads and delivery
• High-quality publications or thought leadership
• Industry experience in pharma, biotech, or related fields
• Fundraising experience at seed/Series A stages

OUR OFFER

Join a team of experienced founders and operators, with tailored guidance, resources, and support. We provide proprietary tools, collaboration with Parkinson’s UK, £250k launch investment, a guaranteed monthly income until launch, majority equity ownership, and ongoing post-spin-out support.

WHO YOU'LL BE JOINING

You will work with Dr. Kiren Baines-Mortimore, a scientific leader with extensive drug discovery and development experience, especially in Parkinson’s disease and biotech entrepreneurship.

ABOUT DSV

Deep Science Ventures creates high-impact science companies across Pharmaceuticals, Climate, Agriculture, and Computation, using a first-principles approach and partnerships with leading institutions.

ABOUT OUR PARTNERSHIP WITH PARKINSON'S UK

This collaboration merges DSV’s invention methodology with Parkinson’s UK’s patient insights, aiming to develop innovative therapies funded by the Parkinson’s Virtual Biotech initiative.